1 ngwa (10 Vials)
| Nnweta: | |
|---|---|
| Ọnụọgụ: | |
▎ Gịnị bụ Vesilute?
Vesilute bụ peptide sịntetik bioactive nke ezinụlọ Havensone peptide, na-egosipụta usoro amino acid bụ isi nke Glu-Asp. Ọ na-arụ ọrụ nchịkwa nchịkwa na anụ ahụ sistemu urinary dị ka eriri afo na prostate site na imetụta mkpụrụ ndụ mkpụrụ ndụ mkpụrụ ndụ iji gbanwee ọrụ physiological na anụ ahụ ndị a.
▎ Vesilute Ọdịdị
Isi mmalite: PubChem |
Usoro: ED Ụdị mkpụrụ ndụ: C 9H 14N 2O7 Ibu ibu: 262.22 g/mol Nọmba CAS: 3918-84-1 PubChem CID: 99716 Synonyms: alfa-Glutamylaspartic acid |
▎ Ovagen Nnyocha
Kedu ihe ndabere nyocha nke Vesilute?
N'ime nyocha nke ihe ndị na-eme ndụ ndụ, peptides enwetala nlebara anya dị ukwuu n'ihi ọrụ dị mkpa ha na-arụ n'ọtụtụ usoro physiological. Vesilute, peptide sịntetik bioactive nke ezinụlọ Havensone peptide, nwere usoro amino acid bụ isi nke Glu-Asp. Nnyocha mbụ na Vesilute dị oke oke. Otú ọ dị, n'ihi myirịta ya na Prostamax-ọzọ Glu-Asp nke nwere peptide n'otu ezinụlọ-ndị ọkà mmụta sayensị chere na ọ nwere ike inwe ọrụ na-emegharị anụ ahụ yiri nke ahụ, si otú ahụ malite njem nke nyocha miri emi.
Nsogbu sistemu urinary, dị ka cystitis na-adịghị ala ala na hyperplasia prostate na-adịghị mma, na-emebi ịdịmma ndụ nke ukwuu, ọkachasị ndị agadi. Achọpụtara Vesilute ka ọ na-enwe mmetụta nchịkwa pụrụ iche na eriri afo na prostate anụ ahụ. Nnyocha e mere na-esochi jiri nwayọọ nwayọọ gosi na ọ nwere ike imetụta mbufụt na-adịghị ala ala na anụ ahụ prostate site na-emetụta mkpụrụ ndụ ihe nketa na ọkwa cellular. Ọ na-edozi isi ihe na-egosi mkpali dị ka ọzịza anụ ahụ, nchichi, na infiltration cell, na-enye ụzọ ọhụrụ iji gboo nsogbu urological.
Kedu ihe ọmụmụ ngwa nke Vesilute?
Nchọpụta Iwu Ezubere iche maka Ọrịa Sistemu Urinary
Dị ka peptide na-achịkwa bioactive n'ime ezinụlọ Havensone, Vesilute nwere ọnọdụ etiti na nyocha ọrịa sistemu urinary. Ọmụmụ ya na-elekwasị anya na ọnọdụ ndị metụtara afọ dị ka cystitis na-adịghị ala ala na hyperplasia prostatic prostate (BPH), na-eme ka microcirculation prostate na-egbochi mgbasa cell na-adịghị mma. Ọ na-ebelata ọzịza nke anụ ahụ prostate, na-ebelata ntinye mkpụrụ ndụ mkpali, ma na-ebelata mgbaàmà adịghị arụ ọrụ nke urinary dị ka mmamịrị ugboro ugboro na ngwa ngwa. Mmetụta usoro nhazi nke akụkụ a nwere ike ịmetụta njikwa epigenetic na mgbanwe njupụta nke chromosomal-usoro cellular na-ekerịta n'etiti Havensone peptides-na-eme ka ndị na-abụghị ọgwụ na-eme ihe maka ọrịa urological degenerative.
Nchọgharị agbasawanye na ọrụ ọmụmụ na arụrụ arụ dị nro
Vesilute na-egosiputa ikike nchịkwa physiological nke anụ ahụ obe. Na ahụike ọmụmụ, ọmụmụ ndị Russia na-egosi na ọ na-eme ka mmepụta spam, motility, na morphology nkịtị, na-eme ka ikike ọmụmụ dịkwuo mma site n'ịkwalite microenvironment cell germ. A na-ekpughere mmetụta mgbochi mkpokọta ya na eriri afọ dị nro nke ọma, nwere ike imetụta nkwekọrịta akwara dị nro site na ịhazi ọrụ enzyme metụtara glycogen metabolism-na-enye nghọta ọhụrụ n'ime usoro mkpụrụ ndụ nke eriri afọ dysmotility.
Mmechi
Dị ka peptide na-achịkwa bioactive n'ime ezinụlọ Havensone, Vesilute na-egosipụta nyocha ngwa dị iche iche nwere uru doro anya. Na isi ngwa ngwa, ọ na-egosiputa irè pụtara ìhè na-etinye aka na nsogbu nke usoro urinary. Site n'ịchịkwa microcirculation prostate na ibelata nzaghachi mkpali, ọ na-ebelata ọzịza anụ ahụ, nchikota, na ọrịa urinary na-akpata site na cystitis na-adịghị ala ala na hyperplasia prostate na-adịghị mma, na-enye usoro ntinye aka na-abụghị nke ọgwụ maka ọrịa urinary degenerative na-emetụta afọ nke jupụtara na ndị agadi. Na ahụike ọmụmụ, ọ na-ebuli mkpụrụ sperm, motility, na morphology oke, na-enye ụzọ ọhụrụ maka nyocha nkwalite ọmụmụ. Mmetụta nchịkwa ya na eriri afo na-arụ ọrụ nke ọma na-enyekwa nghọta n'ime usoro dysmotility eriri afo.
Site n'ịgbasa mkpa na-enweghị isi na urology na ahụike ịmụ nwa, Vesilute na-ejupụta oghere na ntinye aka nke ọrịa, na-atọ ntọala maka ịmepụta nchekwa nchekwa, usoro nhazi nke ezubere iche. Ọ na-eme ka nghọta nke usoro nhazi usoro ndu n'ime ezinụlọ Havensone peptide, na-aga n'ihu na omimi nyocha na nhazi nke akụkụ ahụ yana njikwa usoro physiological nke ihe peptide. Nke a na-enye ntọala usoro mmụta dị mkpa na nnwale maka mmepe biopharmaceutical peptide na-esote, na-ekere oke ọrụ.
Banyere Onye dere ya
Ihe niile a kpọtụrụ aha n'elu bụ Cocer Peptides na-enyocha, dezie ma chịkọta ya.
Edemede na ozi ngwaahịa niile enyere na webụsaịtị a bụ naanị maka mgbasa ozi na ebumnuche mmụta.
Ngwaahịa ndị enyere na webụsaịtị a bụ naanị maka nyocha in vitro. A na-eme nyocha in vitro (Latin: * na iko *, nke pụtara na ihe eji enyo) na mpụga ahụ mmadụ. Ngwaahịa ndị a abụghị ọgwụ, ndị US Food and Drug Administration (FDA) akwadobeghị ya, ha agaghịkwa eji ya gbochie, gwọọ, ma ọ bụ gwọọ ọnọdụ ahụike ọ bụla, ọrịa, ma ọ bụ ọrịa. Iwu amachibidoro nke ọma iwebata ngwaahịa ndị a n'ime ahụ mmadụ ma ọ bụ anụmanụ n'ụdị ọ bụla.